RWD74 USE OF RWE TO INFORM SURVIVAL EXTRAPOLATION IN HEALTH ECONOMIC APPRAISALS OF CANCER DRUGS IN SWEDEN: A REVIEW OF NATIONAL HEALTH ECONOMIC REPORTS 2010-2024
Abstract
Authors
Emma Söreskog Sophie Langenskiöld Sigrid Klaar Niklas Zethraeus Mariam Kasrashvili